CAMBRIDGE, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today provided a business update and outlook for 2019. “We have an exciting year …
- Multiple Data Readouts from ATTCK-20-03 and ATTCK-17-01 Expected in 2019 - - Initial Data on ATTCK-34-01, Unum’s First Program in Solid Tumors, Expected in Second Half of 2019 - - First Development Candidate from BOXR Platform Advancing Toward Clinical …
NEWTOWN, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today announced that its wholly owned subsidiary, NeuroHabilitation …
TORONTO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Eve & Co Incorporated (the “Company” or “Eve & Co”) (TSXV: EVE; OTCQB: EEVVF) is pleased to announce that Shari Mogk-Edwards has been appointed to its board of directors. Ms. Mogk-Edwards’ previous career …
LANGHORNE, Pa., Jan. 03, 2019 (GLOBE NEWSWIRE) -- To our Alliqua Shareholders: I hope you have seen our recent exciting announcements that we believe drove the increase in our market capitalization and liquidity over the past couple of months. Based on the …
- DEXYCUTM commercial launch now expected in 1Q19, earlier than prior guidance of 1H19 - - YUTIQTM commercial launch on track for 1Q19 - WATERTOWN, Mass., Jan. 03, 2019 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals (NASDAQ: EYPT), a specialty …
Second Gene Therapy to Enter Clinic at Nationwide Children’s Hospital for Neurologic Lysosomal Storage Disorders Initial Safety is Encouraging with No Serious Adverse Events at One Month CRANBURY, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Amicus Therapeutics …
DENVER, Jan. 03, 2019 (GLOBE NEWSWIRE) -- The Simply Good Foods Company (NASDAQ: SMPL) (“Simply Good Foods,” or the “Company”), a developer, marketer and seller of branded nutritional foods and snacking products, today reported financial results for the …
SAN DIEGO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ: ARCT), a leading RNA medicines company focused on the development and commercialization of therapeutics towards rare, infectious, fibrotic, and respiratory diseases with …
LONG BEACH, CA, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Nemus Bioscience, Inc. (OTCQB: NMUS), a biopharmaceutical company focused on bioengineered cannabinoid-based therapeutics to address global medical indications, announced today that CEO …
Axovant’s CEO, Pavan Cheruvu, M.D., will be presenting at the J.P. Morgan Healthcare Conference at 8:00 a.m. PST on Thursday, January 10th, 2019 Initial clinical data expected in first half of 2019 from the AXO-AAV-GM2 and AXO-Lenti-PD gene therapy …
SAN JOSE, Calif., Jan. 03, 2019 (GLOBE NEWSWIRE) -- DSP Group®, Inc. (NASDAQ: DSPG), a leading global provider of integrative wireless chipset solutions for converging communications, today announced the appointment of Bill Scheffler as Vice President of …
San Diego, Jan. 03, 2019 (GLOBE NEWSWIRE) -- Emerald Health Pharmaceuticals Inc. (EHP), a clinical-stage company developing medicines based on cannabinoid science, announced today that CEO, Dr. Jim DeMesa, will be featured as a keynote speaker at the …
BUFFALO, N.Y., Jan. 03, 2019 (GLOBE NEWSWIRE) -- CTG, Inc. (NASDAQ: CTG) hereby referred to as "CTG" or the "Company," a leading provider of information technology (IT) solutions and services in North America and Western Europe, today …
Dublin, Jan. 03, 2019 (GLOBE NEWSWIRE) -- The "India Diesel Based Lighting Towers Market, By Type (1500 RPM and 3000 RPM), By End User (Construction, Mining, Event Management and Others), Competition Forecast & Opportunities, 2013-2023" …
LAFAYETTE, La., Jan. 03, 2019 (GLOBE NEWSWIRE) -- LHC Group, Inc. (NASDAQ: LHCG) announced today that the Company is presenting at the 37th Annual J.P. Morgan Healthcare Conference in San Francisco on Thursday, January 10, 2019. The presentation will begin …
Proposed combined company's peptide-nucleic acid antisense oligonucleotide (PATrOL™) technology platform enables rapid development of therapies delivered systemically for genetic diseases Initial indications include RNA gene silencing for Huntington’s …
THIRD QUARTER RESULTS MELVILLE, N.Y., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Park Electrochemical Corp. (NYSE-PKE) reported results for the 2019 fiscal year’s third quarter ended November 25, 2018. As previously reported, Park completed the sale of its …
NEW YORK, Jan. 03, 2019 (GLOBE NEWSWIRE) -- RPT Realty (“RPT” or the “Company”) (NYSE: RPT) today announced that it completed six dispositions with an aggregate sale price of $123.0 million in 2018, with all the closings occurring in the fourth quarter. …
Kansas City, MO, Jan. 03, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- DataSource, Inc., a leading provider of end-to-end integrated branded supply chain managed services, today announced that one of the world’s leading advertising agencies has signed a …
01 days 23:34:23
